Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
IndieBio
AddedFeb 13, 2024
UpdatedJun 28, 2026
IndieBio

IndieBio

Operating

IndieBio: The leading biotech startup accelerator powered by SOSV.

Location
San Francisco, CA, US
Founded
2014
Firm
Compare
Portfolio
Fundraising
Employees
News
Website

IndieBio is a leading biotech startup accelerator powered by SOSV. The firm focuses on early-stage investments in biotechnology companies, typically providing seed and pre-seed funding. IndieBio's portfolio spans a wide range of biotech sectors, including synthetic biology, cellular agriculture, medical devices, and sustainable materials.

Notable portfolio companies include Upside Foods, Endless West, and MycoWorks. IndieBio offers a comprehensive program that includes funding, lab space, and mentorship to help startups accelerate their growth. The accelerator's unique value proposition lies in its deep industry expertise and extensive network in the biotech ecosystem, enabling portfolio companies to rapidly advance their technologies and secure follow-on funding.

IndieBio - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments262
Current Portfolio Count118
Total Portfolio Exits1

Top Investment Stages

Seed116 (45.7%)
Convertible Note63 (24.8%)
Pre-Seed42 (16.5%)
Series A23 (9.1%)
Series B10 (3.9%)

Stage Mix

Seed 46%Convertible Note 25%Pre-Seed 17%Series A 9%Series B 4%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Sun Genomics logo

Sun Genomics

unlocked labs logo

unlocked labs

Prellis Biologics logo

Prellis Biologics

Hypercell Technologies logo

Hypercell Technologies

Lillianah logo

Lillianah

RizLab Health logo

RizLab Health

BioAesthetics logo

BioAesthetics

Gatehouse Bio logo

Gatehouse Bio

Earnest Agriculture logo

Earnest Agriculture

Calder Biosciences logo

Calder Biosciences

QuantumCyte logo

QuantumCyte

Cell BioEngines logo

Cell BioEngines

California Cultured logo

California Cultured

Stämm logo

Stämm

Beeflow logo

Beeflow

Cayuga Biotech logo

Cayuga Biotech

Dnalite Therapeutics logo

Dnalite Therapeutics

BiomeSense logo

BiomeSense

Aluna logo

Aluna

Maa'Va logo

Maa'Va

Michroma logo

Michroma

Atlantic Fish logo

Atlantic Fish

Cybele Microbiome logo

Cybele Microbiome

Prolific Machines logo

Prolific Machines

Aja Labs logo

Aja Labs

IndieBio - Similar Investment Firms

Petri logo

Petri

petri.bio

RebelBio logo

RebelBio

sosv.com

Emerald Bioventures logo

Emerald Bioventures

MarsBio logo

MarsBio

marsbio.vc

Mission BioCapital logo

Mission BioCapital

Global Bio Fund logo

Global Bio Fund

Accelerator logo

Accelerator

Dcvc Bio logo

Dcvc Bio

dcvc.com

Ambition VC logo

Ambition VC

BioCrossroads logo

BioCrossroads

biocrossroads.com

Woodside Incubator logo

Woodside Incubator

Betaspring logo

Betaspring

betaspring.com

Underdog Labs logo

Underdog Labs

underdoglabs.io

futureland logo

futureland

Colaborativox logo

Colaborativox

colaborativox.com

IndieBio - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 7300Business Services
Show 2 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541000Professional, Scientific, and Technical Services